Projects

POCTRN – Point of Care Technologies for Nutrition, Infection and Cancer for Global Health (PORTENT) Study: Evaluation and selection of a total of five (05) Point-of-Care Devices for Nutrition, Infection, and Cancer for Global Health for validation over a 5-year period.

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2023 - 2028

Project Lead

Dr Tony Raj

Authors

Dr Tony Raj,Dr Dhinagaran D, Dr Verghese Thomas, Dr. Bharat Kalidindi.Dr. Ryan Fernandes

Project Status

ongoing

Project Type

NIH–NIBIB POCTRN